Ascendiant Capital Markets Cuts HeartSciences (NASDAQ:HSCS) Price Target to $8.00
HeartSciences (NASDAQ:HSCS – Free Report) had its price objective decreased by Ascendiant Capital Markets from $9.00 to $8.00 in a research report report published on Tuesday,Benzinga reports. Ascendiant Capital Markets currently has a buy rating on the stock. Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of HeartSciences in a research report on […]
27 Mar 05:38 · The Markets Daily